media – Page 629 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

FDA Approves Symbiomix Therapeutics’ Solosec™ (secnidazole) Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women

Symbiomix Therapeutics announced the U.S. Food and Drug Administration (FDA) has approved its lead product Solosec™ (secnidazole) 2g oral granules for the treatment of bacterial vaginosis (BV) in adult women.
- Source: news.pharmacodia
- 426
- September 22, 2017
bacterial vaginosis FDA New Approvals
The world is running out of antibiotics, WHO says

(CNN)Too few new antibiotics are under development to combat the threat of multidrug-resistant infections, according to a new World Health Organization report published Tuesday. Adding to the concern: It is likely that the speed of increasing resistance will outpace the slow drug development process.
- Source: edition
- 661
- September 22, 2017
antibiotics Researches WHO
IDbyDNA and ARUP Laboratories introduce diagnostic test for pneumonia

ARUP Laboratories and metagenomics firm IDbyDNA have introduced a new next-generation sequencing (NGS) test, Explify Respiratory, for the diagnosis of respiratory diseases such as pneumonia.
- Source: medicaldevice-network
- 620
- September 21, 2017
NGS pneumonia Researches respiratory
Medtronic secures FDA approval for Intellis spinal cord stimulator

Medtronic has secured the US Food and Drug Administration (FDA) approval for its next generation spinal cord stimulator branded as Intellis platform for the management of certain forms of chronic intractable pain.
- Source: medicaldevices-business-review
- 1,001
- September 21, 2017
chronic Company Insight spinal cord stimulator
Ipsen receives approval from European Commission for Xermelo®

Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, announced that the European Commission(EC) has approved Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy.
- Source: Ipsen
- 494
- September 21, 2017
biopharmaceutical New Approvals SSA
7th Annual Congress on Clinical Microbiology

End Date: Tuesday, 26 September, 2017 5:00pm Clinical Microbiology 2017 is a premier forum to evaluate latest innovations in the field of Clinical Microbiology and Microbial Genomics. Clinical Microbiology-2017 graciously solicits the presence of presenters, speakers, students, and exhibitors from all over the world to Chicago, Illinois, USA on September 25th-26th, 2017.
- Source: conferenceseries.com
- 677
- September 21, 2017
Clinical Exhibitions & Activities Microbiology
Dental Expo Moscow

Dental-Expo Moscow will be one of the most eagerly anticipated shows dealing with international dental exhibition. The Dental Expo Moscow will also consist of a forum. The Dental Expo Moscow that is scheduled to take place in Moscow, will display the innovations and technologies in the dental world. The visitors of the fair will be able to acquire a lot of information on the latest products and innovations in the related industry.
- Source: medical-events
- 875
- September 21, 2017
dental Exhibitions & Activities
China’s Import and Export Market of Obstetrics and Gynecology Equipment

Development of technology over the past couple of decades has led to societal and cultural development which in turn has resulted in awareness of issues such as the importance of women’s health. With vast improvements taking place in this field, obstetrics and gynecology equipment has experienced major changes.
- Source: Ddu
- 1,281
- September 20, 2017
export gynecology import Market Reports obstetrics
UOW researchers secure grant to develop new medical device for bedside brain monitoring

A University of Otago, Wellington (UOW) team has been awarded an MBIE Endeavour grant to develop a non-invasive and cost-effective device to diagnose and treat stroke and other brain injuries.
- Source: medicaldevices-business-review
- 700
- September 20, 2017
brain non-invasive Researches stroke
Centinel Spine acquires Prodisc assets from J&J’s DePuy Synthes

Centinel Spine has agreed to acquire Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes’ Prodisc assets for an undisclosed amount, according to an OrthoWorld report.
- Source: Massdevice
- 667
- September 20, 2017
acquisition Market Views Prodisc

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.